Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Equity Premium Income ETF (JEPI) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

JPMorgan Equity Premium Income ETFTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

JPMorgan Equity Premium Income ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? JPMorgan Equity Premium Income ETF trades at $57.02 (market cap $45.63B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: JPMorgan Equity Premium Income ETF is far larger — about 4.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while JPMorgan Equity Premium Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Equity Premium Income ETF for 58 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

JEPIRDY
Market Cap
$45.63B$10.61B
Volume
4,550,9463,738,869
Sector
Income / Options OverlayHealth
52-Week High
$59.88$15.38
52-Week Low
$55.29$11.38
Typical Hold Time
58 Days0 Days
Enterprise Value
—$10.51B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Equity Premium Income ETF

JEPI trades at $56.93, showing minimal daily movement with a slight decline of 0.05%. The ETF maintains a bullish technical outlook with strong moving average signals, though oscillators suggest neutral momentum. Recent dividend distributions of $0.34-$0.37 demonstrate consistent income generation, while financial media coverage highlights JEPI's role in income-focused portfolios and its appeal to retirees seeking monthly distributions.

JEPI presents as a stable income vehicle with reliable dividend payments, though valuation metrics remain unavailable for fundamental assessment. The ETF's covered call strategy provides downside protection but may limit upside potential during strong market rallies. Key risks include interest rate sensitivity and the trade-off between income generation and capital appreciation in rising markets.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JEPI
95% Buy5% Sell
Avg holding period · 58 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About JPMorgan Equity Premium Income ETF

JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.

Read more on JEPI →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →